{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:56:03Z","timestamp":1776128163939,"version":"3.50.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11940-018-0512-7","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T08:56:42Z","timestamp":1527497802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update on Idiopathic Intracranial Hypertension"],"prefix":"10.1007","volume":"20","author":[{"given":"Sivashakthi","family":"Kanagalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem S.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"512_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159\u201365.","journal-title":"Neurology"},{"key":"512_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S1474-4422(06)70442-2","volume":"5","author":"AK Ball","year":"2006","unstructured":"Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 2006;5:433\u201342.","journal-title":"Lancet Neurol"},{"key":"512_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","volume":"45","author":"FJ Durcan","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875\u20137.","journal-title":"Arch Neurol"},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archneur.1993.00540010072020","volume":"50","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50:78\u201380.","journal-title":"Arch Neurol"},{"key":"512_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/ene.12442","volume":"21","author":"A Kesler","year":"2014","unstructured":"Kesler A, Stolovic N, Bluednikov Y, et al. The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol. 2014;21:1055\u20139.","journal-title":"Eur J Neurol"},{"key":"512_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"\u2022\u2022 Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: mechanisms, management and future directions. Lancet Neurol. 2016;15:78\u201391. An important review by one of the top IIH research teams that synthesizes much of our understanding of the pathogenesis of this disease and makes progress toward removing the term \u201cidiopathic\u201d from the process.","journal-title":"Lancet Neurol"},{"key":"512_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/WNL.42.4.851","volume":"42","author":"J Malm","year":"1992","unstructured":"Malm J, Kristensen B, Markgren P, et al. CSF hydrodynamics in idiopathic intracranial hypertension: a long term study. Neurology. 1992;42:851\u20138.","journal-title":"Neurology"},{"key":"512_CR8","first-page":"223","volume":"19","author":"K Markey","year":"2016","unstructured":"\u2022 Markey K, Uldall M, Botfield H, et al. Idiopathic intracranial hypertension, hormones, and 11\u03b2-hydroxysteroid dehydrogenases. J Pain Res. 2016;19:223\u201332. Groundwork for a possible directed IIH therapy.","journal-title":"J Pain Res"},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00128071-200506010-00004","volume":"6","author":"DI Friedman","year":"2005","unstructured":"Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29\u201337.","journal-title":"Am J Clin Dermatol"},{"key":"512_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1600-0404.2004.00327.x","volume":"110","author":"A Kesler","year":"2004","unstructured":"Kesler A, Goldhammer Y, Hadayer A, et al. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand. 2004;110:408\u201311.","journal-title":"Acta Neurol Scand"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2011-302029","volume":"83","author":"B Biousse","year":"2012","unstructured":"Biousse B, Bruce B, Newman N. Update of the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neruosurg Psychiatry. 2012;83:488\u201394.","journal-title":"J Neurol Neruosurg Psychiatry"},{"key":"512_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1468-2982.1990.1006331.x","volume":"10","author":"M Wall","year":"2002","unstructured":"Wall M. The headache profile of intracranial hypertension. Cephalagia. 2002;10:331\u20135.","journal-title":"Cephalagia"},{"key":"512_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/IIO.0000000000000007","volume":"54","author":"CE Francis","year":"2014","unstructured":"Francis CE, Quiros PA. Headache management in idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54:103\u201314.","journal-title":"Int Ophthalmol Clin"},{"key":"512_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/WNO.0000000000000205","volume":"35","author":"S Bidot","year":"2015","unstructured":"Bidot S, Bruce B, Saindane A, et al. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:31\u20136.","journal-title":"J Neuroophthalmol"},{"key":"512_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archneur.1982.00510200003001","volume":"39","author":"J Corbett","year":"1982","unstructured":"Corbett J, Savino P, Thompson H, et al. Visual loss in pseudotumour cerebri. Arch Neurol. 1982;39:461\u201374.","journal-title":"Arch Neurol"},{"key":"512_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/eye.1998.18","volume":"12","author":"F Rowe","year":"1998","unstructured":"Rowe F, Sarkies N. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye. 1998;12:111\u20138.","journal-title":"Eye"},{"key":"512_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/brain\/114.2.1112","volume":"114","author":"M Wall","year":"1991","unstructured":"Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991;114:155\u201380.","journal-title":"Brain"},{"key":"512_CR18","first-page":"134","volume":"39","author":"M Wall","year":"1998","unstructured":"Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective intraocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998;39:134\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"512_CR19","unstructured":"Wall M. The morphology of visual field damage in idiopathic intracranial hypertension: an anatomic region analysis. In: Miss RP, Heijl A, editors. Perimetry update: Kugler Publications; 1991. p. 20\u20137."},{"key":"512_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11916-007-0024-8","volume":"11","author":"DI Friedman","year":"2007","unstructured":"Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep. 2007;11:62\u20138.","journal-title":"Curr Pain Headache Rep"},{"key":"512_CR21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1136\/bjophthalmol-2016-309852","volume":"101","author":"M Wall","year":"2017","unstructured":"Wall M, Thurtell MJ, NORDIC Idiopathic Intracranial Hypertension Study Group. Optic disc hemorrhages at baseline as a risk factor for poor outcome in idiopathic intracranial hypertension treatment trial. Br J Ophthalmol. 2017;101:1256\u201360.","journal-title":"Br J Ophthalmol"},{"key":"512_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","volume":"45","author":"L Frisen","year":"1982","unstructured":"Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatr. 1982;45:13\u20138.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"512_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/08820538.2010.518462","volume":"25","author":"HG Rizzo","year":"2010","unstructured":"Rizzo HG. Use of optical coherence to evaluate papilledema and pseudopapilledema. Semin Ophthalmol. 2010;25:198\u2013205.","journal-title":"Semin Ophthalmol"},{"key":"512_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/bjo.2004.049486","volume":"89","author":"EZ Karam","year":"2005","unstructured":"Karam EZ, Hedges TR. Optical coherence tomography of the retinal nerve fiber layer in mild papiloedema and pseudopapilloedema. Br J Ophthalmol. 2005;89:294\u20138.","journal-title":"Br J Ophthalmol"},{"key":"512_CR25","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1167\/iovs.08-2528","volume":"50","author":"G Bebolleda","year":"2009","unstructured":"Bebolleda G, Munoz-Negrete FJ. Follow up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:5197\u2013200.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"512_CR26","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1167\/iovs.12-9438","volume":"53","author":"J Wang","year":"2012","unstructured":"Wang J, Kardon R, Kupersmith M, et al. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical conherence tomography. Invest Ophthalmol Vis Sci. 2012;53:4069\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"512_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clineuro.2015.05.002","volume":"136","author":"S Ahuja","year":"2015","unstructured":"Ahuja S, Anand D, Dutta TK, et al. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography\u2014a case control study. Clin Neurol Neurosurg. 2015;136:95\u20139.","journal-title":"Clin Neurol Neurosurg"},{"key":"512_CR28","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1167\/iovs.14-14961","volume":"55","author":"P Auinger","year":"2014","unstructured":"OCT Sub-study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, et al. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55:8173\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"512_CR29","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.ophtha.2015.06.003","volume":"122","author":"Optical Coherence Tomography Sub-study Committee","year":"2015","unstructured":"\u2022\u2022 Optical Coherence Tomography Sub-study Committee, NORDIC Idiopathic Intracranial Hypertension Study Group. Papilledema outcomes from the Optical Coherence Tomography Sub-study of the Idiopathic intracranial hypertension treatment trial. Ophthalmology. 2015;122:1939\u201345. Prospective, systematic demonstration of the utility of OCT in the long-term surveillance and management of patients with IIH; uses methods that overcome limitations of prior techniques.","journal-title":"Ophthalmology"},{"key":"512_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/WNO.0000000000000303","volume":"35","author":"S Bidot","year":"2015","unstructured":"Bidot S, Saindane AM, Peragallo JH, et al. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:400\u201311.","journal-title":"J Neuroophthalmol"},{"key":"512_CR31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/S0161-6420(98)99039-X","volume":"105","author":"MC Brodsky","year":"1998","unstructured":"Brodsky MC, Vaphiades M. Magnectic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998;105:1686\u201393.","journal-title":"Ophthalmology"},{"key":"512_CR32","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/01.WNL.0000066683.34093.E2","volume":"60","author":"RI Farb","year":"2003","unstructured":"Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60:1418\u201324.","journal-title":"Neurology"},{"key":"512_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00041327-200020010-00004","volume":"20","author":"AG Lee","year":"2000","unstructured":"Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol. 2000;20:12\u20133.","journal-title":"J Neuroophthalmol"},{"key":"512_CR34","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1212\/01.wnl.0000242704.60275.e9","volume":"67","author":"W Whiteley","year":"2006","unstructured":"Whiteley W, Al-Shahi R, Warlow CP, et al. CSF opening pressure: reference interval and the effect of the body mass index. Neurology. 2006;67:1690\u20131.","journal-title":"Neurology"},{"key":"512_CR35","first-page":"342","volume":"25","author":"R Wong","year":"2017","unstructured":"Wong R, Madill SA, Pandey P, et al. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol. 2017;25:342\u20134.","journal-title":"BMC Ophthalmol"},{"key":"512_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2014.3312","volume":"311","author":"M Wall","year":"2014","unstructured":"\u2022\u2022 NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, MP MD, Kieburtz JD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial treatment trial. JAMA. 2014;311:1641\u201351. Landmark prospective study evaluating the efficacy of acetazolamide in the treatment of patients with IIH.","journal-title":"JAMA"},{"key":"512_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","volume":"36","author":"MW Hove ten","year":"2016","unstructured":"ten Hove MW, Friedman DI, Patel AD, et al. Safety and tolerability of acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016;36:13\u20139.","journal-title":"J Neuroophthalmol"},{"key":"512_CR38","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00415-015-7838-9","volume":"262","author":"JC Kattah","year":"2015","unstructured":"Kattah JC, Pula JH, Mejico LJ, et al. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neurol. 2015;262:2271\u20134.","journal-title":"J Neurol"},{"key":"512_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/head.13153","volume":"57","author":"DI Friedman","year":"2017","unstructured":"\u2022 Friedman DI, Quiros PA, Subramanian PS, et al. Headache in idiopathic intracranial hypertension: findings from the Idiopathic Intracranial Hypertension Treatment Trial. Headache. 2017;57:1195\u2013205. Demonstrates lack of a relationship between ICP lowering and headache relief in a large prospectively treated cohort.","journal-title":"Headache"},{"key":"512_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0404.2007.00905.x","volume":"116","author":"N Celebisoy","year":"2007","unstructured":"Celebisoy N, Gokcay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322\u20137.","journal-title":"Acta Neurol Scand"},{"key":"512_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/088307389400900205","volume":"9","author":"JF Schoeman","year":"1994","unstructured":"Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130\u20134.","journal-title":"J Child Neurol"},{"key":"512_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","volume":"68","author":"M Thiambisetty","year":"2007","unstructured":"Thiambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68:229\u201332.","journal-title":"Neurology"},{"key":"512_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/0333102414534329","volume":"35","author":"B Wakerley","year":"2015","unstructured":"Wakerley B, Tan M, Ting E. Idiopathic intracranial hypertension. Cephalalgia. 2015;35:248\u201361.","journal-title":"Cephalalgia"},{"key":"512_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/WNO.0000000000000181","volume":"35","author":"JL Rizzo","year":"2015","unstructured":"Rizzo JL, Lam KV, Wall M, et al. Perimetry, retinal nerve fiber layer thickness and papilledema grades after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:22\u20135.","journal-title":"J Neuroophthalmol"},{"key":"512_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/WNO.0000000000000106","volume":"34","author":"LC Huang","year":"2014","unstructured":"Huang LC, Winter TW, Herro AM, et al. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuroophthalmol. 2014;34:223\u20138.","journal-title":"J Neuroophthalmol"},{"key":"512_CR46","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1177\/0333102411423305","volume":"31","author":"AJ Sinclair","year":"2011","unstructured":"Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31:1627\u201333.","journal-title":"Cephalalgia"},{"key":"512_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3171\/jns.2004.101.4.0627","volume":"101","author":"MJ McGirt","year":"2004","unstructured":"McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement of pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004;101:627\u201332.","journal-title":"J Neurosurg"},{"key":"512_CR48","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/foc.2001.10.2.2","volume":"10","author":"CO Maher","year":"2001","unstructured":"Maher CO, Garrity JA, Meyer FB. Refractory idiopathic intracranial hypertension treated with stereotactically planned ventriculopertioneal shunt placement. Neurosurg Focus. 2001;10:E1.","journal-title":"Neurosurg Focus"},{"key":"512_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1212\/WNL.43.6.1071","volume":"43","author":"MI Rosenberg","year":"1993","unstructured":"Rosenberg MI, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology. 1993;43:1071\u20132.","journal-title":"Neurology"},{"key":"512_CR50","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/WNL.46.6.1524","volume":"46","author":"ER Eggenberger","year":"1996","unstructured":"Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524\u201330.","journal-title":"Neurology"},{"key":"512_CR51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1046\/j.1474-7766.2002.00084.x","volume":"2","author":"CJ Lueck","year":"2002","unstructured":"Lueck CJ, McIlwaine GG. Idiopathic intracranial hypertension. Pract Neurol. 2002;2:262\u201371.","journal-title":"Pract Neurol"},{"key":"512_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/02688697.2010.544781","volume":"25","author":"K Abubaker","year":"2011","unstructured":"Abubaker K, Ali Z, Raza K, et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculperitoneal shunts\u2014case series and literature review. Br J Neurosurg. 2011;25:94\u20139.","journal-title":"Br J Neurosurg"},{"key":"512_CR53","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/bjo.48.10.522","volume":"48","author":"SS Hayreh","year":"1964","unstructured":"Hayreh SS. Pathogenesis of oedema of the optic disc. A preliminary report. Br J Ophthalmol. 1964;48:522\u201343.","journal-title":"Br J Ophthalmol"},{"key":"512_CR54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2007.05.034","volume":"144","author":"Z Yazici","year":"2007","unstructured":"Yazici Z, Yazici B, Tuncel E. Findings of magnetic resonance imaging after optic nerve sheath decompression in patients with idiopathic intracranial hypertension. Am J Ophthalmol. 2007;144:429\u201335.","journal-title":"Am J Ophthalmol"},{"key":"512_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/IOP.0000000000000326","volume":"31","author":"RK Sobel","year":"2015","unstructured":"Sobel RK, Syed NA, Carter KD, et al. Optic nerve sheath fenestration: current preferences in surgical approach and biopsy. Ophthal Plast Reconstr Surg. 2015;31:310\u20132.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"512_CR56","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/FOC-07\/11\/E6","volume":"23","author":"SE Feldon","year":"2007","unstructured":"Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus. 2007;23:E6.","journal-title":"Neurosurg Focus"},{"key":"512_CR57","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0161-6420(00)00340-7","volume":"107","author":"JT Banta","year":"2000","unstructured":"Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907\u201312.","journal-title":"Ophthalmology"},{"key":"512_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/01676830.2016.1139592","volume":"35","author":"V Starks","year":"2016","unstructured":"Starks V, Gilliland G, Vrcek I, et al. Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness. Orbit. 2016;35:87\u201390.","journal-title":"Orbit"},{"key":"512_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.clineuro.2015.05.020","volume":"137","author":"EE Obi","year":"2015","unstructured":"Obi EE, Lakhani BK, Burns J, et al. Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary center. Clin Neurol Neurosurg. 2015;137:94\u2013101.","journal-title":"Clin Neurol Neurosurg"},{"key":"512_CR60","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archopht.1993.01090050066030","volume":"111","author":"TC Spoor","year":"1993","unstructured":"Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111:632\u20135.","journal-title":"Arch Ophthalmol"},{"key":"512_CR61","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bjophthalmol-2014-304953","volume":"98","author":"PL Fonseca","year":"2014","unstructured":"Fonseca PL, Rigamonti D, Miller NR, et al. Visual outcomes of surgical intervention for pseudotumor cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol. 2014;98:1360\u20133.","journal-title":"Br J Ophthalmol"},{"key":"512_CR62","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ophtha.2010.06.025","volume":"118","author":"AH Alsuhaibani","year":"2011","unstructured":"Alsuhaibani AH, Carter KD, Nerad JA, et al. Effect of optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. Ophthalmology. 2011;118:412\u20134.","journal-title":"Ophthalmology"},{"key":"512_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/IIO.0000000000000010","volume":"54","author":"HE Killer","year":"2014","unstructured":"Killer HE, Subramanian PS. Compartmentalized cerebrospinal fluid. Int Ophthalmol Clin. 2014;54:95\u2013102.","journal-title":"Int Ophthalmol Clin"},{"key":"512_CR64","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0161-6420(93)31588-5","volume":"100","author":"JL Plotnik","year":"1993","unstructured":"Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100:683\u201390.","journal-title":"Ophthalmology"},{"key":"512_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1442-9071.2006.01301.x","volume":"34","author":"S Chandrasekaran","year":"2006","unstructured":"Chandrasekaran S, McCluskey P, Minassian D, et al. Visual outcomes for optic nerve sheath fenestration in pseudotumor cerebri and related conditions. Clin Exp Ophthalmol. 2006;34:661\u20135.","journal-title":"Clin Exp Ophthalmol"},{"key":"512_CR66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0b013e31827debd6","volume":"80","author":"BD Riggeal","year":"2013","unstructured":"Riggeal BD, Bruce BB, Saindane AM, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology. 2013;80:289\u201395.","journal-title":"Neurology"},{"key":"512_CR67","unstructured":"Stranding S, Ellis H, Healy JC et al. 2005 Gray\u2019s anatomy: the anatomical basis of clinical practice. 39th Ed Edinburgh: Elsevier Churchill Livingstone."},{"key":"512_CR68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ca.20911","volume":"23","author":"MA Strydom","year":"2010","unstructured":"Strydom MA, Briers N, Bosman MC, et al. The anatomical basis of venographic filing defects of the transverse sinus. Clin Anat. 2010;23:153\u20139.","journal-title":"Clin Anat"},{"key":"512_CR69","first-page":"677","volume":"17","author":"J Roche","year":"1996","unstructured":"Roche J, Warner D. Arachnoid granulations in the transverse and sigmoid sinuses: CT, MR, and MR angiographic appearance of a normal anatomic variation. Am J Neuroradiol. 1996;17:677\u201383.","journal-title":"Am J Neuroradiol"},{"key":"512_CR70","first-page":"1523","volume":"17","author":"J Leach","year":"1996","unstructured":"Leach J, Jones BV, Tomsick T, et al. Normal appearance of Arachnoid granulations on contrast-enhanced CT and MR of the brain: differentiation from dural sinus disease. Am J Neuroradiol. 1996;17:1523\u201332.","journal-title":"Am J Neuroradiol"},{"key":"512_CR71","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jvir.2010.02.018","volume":"21","author":"HB Zheng","year":"2010","unstructured":"Zheng HB, Zhou M, Zhao B, et al. Pseudotumor cerebri syndrome and giant arachnoid granulation: treatment with venous sinus stenting. J Vasc Interv Radiolo. 2010;21:927\u20139.","journal-title":"J Vasc Interv Radiolo"},{"key":"512_CR72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1212\/01.wnl.0000299894.30700.d2","volume":"70","author":"A Donnet","year":"2008","unstructured":"Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiological outcome of 10 consecutive patients. Neurology. 2008;70:641\u20137.","journal-title":"Neurology"},{"key":"512_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.58.1.26","volume":"58","author":"JO King","year":"2002","unstructured":"King JO, Mitchell PJ, Thomson KR, et al. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002;58:26\u201330.","journal-title":"Neurology"},{"key":"512_CR74","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10072-004-0368-3","volume":"25","author":"R Simone De","year":"2005","unstructured":"De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005;25:342\u20134.","journal-title":"Neurol Sci"},{"key":"512_CR75","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1468-1331.2008.02340.x","volume":"15","author":"A Stienen","year":"2008","unstructured":"Stienen A, Weinzierl M, Ludolph A, et al. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol. 2008;15:1416\u20138.","journal-title":"Eur J Neurol"},{"key":"512_CR76","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1552-6569.2012.00732.x","volume":"23","author":"A Horev","year":"2013","unstructured":"Horev A, Hallevy H, Plakht Y, et al. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging. 2013;23:375\u20138.","journal-title":"J Neuroimaging"},{"key":"512_CR77","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1212\/01.WNL.0000120750.40453.64","volume":"62","author":"DB Baryshnik","year":"2004","unstructured":"Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology. 2004;62:1445\u20136.","journal-title":"Neurology"},{"key":"512_CR78","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(02)07440-8","volume":"359","author":"JN Higgins","year":"2002","unstructured":"Higgins JN, Owler BK, Cousins C, et al. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359:228\u201330.","journal-title":"Lancet"},{"key":"512_CR79","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3171\/2011.10.JNS101410","volume":"116","author":"DA Kumpe","year":"2012","unstructured":"Kumpe DA, Bennett JL, Seinfeld J, et al. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116:538\u201348.","journal-title":"J Neurosurg"},{"key":"512_CR80","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3171\/jns.2003.98.5.1045","volume":"98","author":"BK Owler","year":"2003","unstructured":"Owler BK, Parker G, Halmagyi, et al. Pseudotumour cerebri syndrome: venous sinus bstruction and its treatment with stent placement. J Neurosurg. 2003;98:1045\u201355.","journal-title":"J Neurosurg"},{"key":"512_CR81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/WNO.0b013e31827f18eb","volume":"33","author":"MG Radvany","year":"2013","unstructured":"Radvany MG, Solomon D, Nijjar S, et al. Visual and neurological outcomes following endovascular stenting for pseudotumour cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33:117\u201322.","journal-title":"J Neuroophthalmol"},{"key":"512_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/neurintsurg-2011-010156","volume":"5","author":"JD Fields","year":"2012","unstructured":"Fields JD, Javedani PP, Falardeau J, et al. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. J Neurointerv Surg. 2012;5:62\u20138.","journal-title":"J Neurointerv Surg"},{"key":"512_CR83","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/jnnp.74.12.1662","volume":"74","author":"JNP Higgins","year":"2003","unstructured":"Higgins JNP, Cousins C, Owler BK, et al. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosur Psychiartry. 2003;74:1662\u20136.","journal-title":"J Neurol Neurosur Psychiartry"},{"key":"512_CR84","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000357503","volume":"3","author":"MS Teleb","year":"2013","unstructured":"Teleb MS, Cziep ME, Lazzaro MA, et al. Idiopathic intracranial hypertension. A systemic analysis. Interv Neurol. 2013;3:132\u201343.","journal-title":"Interv Neurol"},{"key":"512_CR85","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3174\/ajnr.A4377","volume":"36","author":"SR Satti","year":"2015","unstructured":"Satti SR. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory IIH. Am J Neuroradiol. 2015;36:1899\u2013904.","journal-title":"Am J Neuroradiol"},{"key":"512_CR86","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.wneu.2010.11.012","volume":"75","author":"FC Albuquerque","year":"2011","unstructured":"Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 2011;75:648\u201352.","journal-title":"World Neurosurg"},{"key":"512_CR87","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/neurintsurg-2016-012810","volume":"9","author":"DA Kumpe","year":"2017","unstructured":"Kumpe DA, Seinfeld J, Huang X, et al. Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting. J Neurointerv Surg. 2017;9:867\u201374.","journal-title":"J Neurointerv Surg"},{"key":"512_CR88","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3171\/2009.12.JNS09953","volume":"114","author":"J Fridley","year":"2011","unstructured":"Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114:34\u20139.","journal-title":"J Neurosurg"},{"key":"512_CR89","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11695-007-9043-0","volume":"17","author":"F Favretti","year":"2007","unstructured":"Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1791 consecutive obese patients: 12\u00a0year results. Obes Surg. 2007;17:168\u201375.","journal-title":"Obes Surg"},{"key":"512_CR90","first-page":"146","volume":"24","author":"HJL Garton","year":"2004","unstructured":"Garton HJL. Cerebrospinal fluid diversion procedures. J Neurol. 2004;24:146\u201355.","journal-title":"J Neurol"},{"key":"512_CR91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00701-016-3010-2","volume":"159","author":"AV Kalyvas","year":"2017","unstructured":"Kalyvas AV, Hughes M, Koutsarnakis C, et al. Efficacy, complications, and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir. 2017;159:33\u201349.","journal-title":"Acta Neurochir"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-018-0512-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0512-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0512-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T02:23:18Z","timestamp":1720318998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-018-0512-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1007\/s11940-018-0512-7","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"assertion":[{"value":"28 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sivashakthi Kanagalingam declares that she has no potential conflicts of interest.Prem S. Subramanian is supported in part by a Challenge Grant to the Department of Ophthalmology, University of Colorado School of Medicine, from Research to Prevent Blindness, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"24"}}